1 – 5 of 5
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Left ventricular longitudinal function is reduced but partially compensated by increased radial function after heart transplantation
- Contribution to journal › Article
- 2024
-
Mark
Randomized Trial of Cholesterol Lowering With Evolocumab for Cardiac Allograft Vasculopathy in Heart Transplant Recipients
- Contribution to journal › Article
- 2022
-
Mark
Validation of cause of death classification after heart transplantation and cause-specific life expectancy compared to the general population
- Contribution to journal › Article
- 2021
-
Mark
Leflunomide Inhibits rat-to-Mouse Cardiac Xenograft Rejection by Suppressing Adaptive Immune Cell Response and NF-κB Signaling Activation
- Contribution to journal › Article
- 2020
-
Mark
Cholesterol lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De-novo heart transplant recipients : Design of the randomized controlled EVOLVD trial
- Contribution to journal › Article
